Welcome

Hematology franchise overview

Review of key clinical data presented at ASH

Spark Therapeutics, Inc. (SPK-8011) clinical data update

Bruno Eschli, Head of Investor Relations

Peter Ahnesorg, Franchise Head Hematology

Charles Fuchs, Senior Vice President - Global Head Of Oncology And Hematology Product Development

Gallia G. Levy, MD, PhD, Chief Medical and Product Strategy Officer